| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Halobetasol | Halobetasol 21 Chloro Diflorasone | VL2370001 | View CAS 98651-66-2 |
| Halobetasol | cis-Haloperidol N-Oxide | VE009434 | View CAS 150214-94-1 |
Halobetasol Impurities
| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Halobetasol | Halobetasol 21 Chloro Diflorasone | VL2370001 | View CAS 98651-66-2 |
| Halobetasol | cis-Haloperidol N-Oxide | VE009434 | View CAS 150214-94-1 |
| Catalogue No. | VE009434 |
| CAS No. | 150214-94-1 |
| Molecular Formula | C21H23ClFNO3 |
| Molecular Weight | 391.86 g/mol |
| Parent drug | Halobetasol |
| IUPAC Name | 4-[cis-4-(4-Chlorophenyl)-4-hydroxy-1-oxido-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone |
| Synonyms | N/A |
| References | Hanafi, Ibrahem, et al. Haloperidol (Route of Administration) for People with Schizophrenia.” Cochrane Database of Systematic Reviews, Oct. 2017, https://doi.org/10.1002/14651858.cd012833. |
| Status | In-stock |
| ListName | cis-Haloperidol N-Oxide |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
